# Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

> **NCT04126590** · PHASE1 · UNKNOWN · sponsor: **Changchun Intellicrown Pharmaceutical Co. LTD** · enrollment: 39 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **BIOLOGICAL:** KN044

## Key facts

- **NCT ID:** NCT04126590
- **Lead sponsor:** Changchun Intellicrown Pharmaceutical Co. LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-09
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04126590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04126590, "Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04126590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*